In today’s recent session, 0.65 million shares of the Veracyte Inc (NASDAQ:VCYT) have been traded, and its beta is 1.64. Most recently the company’s share price was $28.35, and it changed around $6.53 or 29.93% from the last close, which brings the market valuation of the company to $2.17B. VCYT at last check was trading at a discount to its 52-week high of $29.35, offering almost -3.53% off that amount. The share price’s 52-week low was $18.61, which indicates that the recent value has risen by an impressive 34.36% since then. We note from Veracyte Inc’s average daily trading volume that its 10-day average is 0.86 million shares, with the 3-month average coming to 827.93K.
Veracyte Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.80. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 2 recommended VCYT as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Veracyte Inc (NASDAQ:VCYT) trade information
Instantly VCYT has been showing a green trend so far today with a performance of 29.93% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 28.62 on recent trading dayincreased the stock’s daily price by 0.94%. The company’s shares are currently up 3.05% year-to-date, but still up 18.12% over the last five days. On the other hand, Veracyte Inc (NASDAQ:VCYT) is 33.29% up in the 30-day period. We can see from the shorts that 3.12 million shares have been sold at a short interest cover period of 3.67 day(s).
The consensus price target as assigned by Wall Street analysts is $24.5, which translates to bulls needing to decrease their stock price by -15.71% from its current value. Analyst projections state that VCYT is forecast to be at a low of $23 and a high of $26.
Veracyte Inc (VCYT) estimates and forecasts
Veracyte Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 11.39 percent over the past six months and at a 95.10% annual growth rate that is well above the industry average of 10.90%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -10.52%.
VCYT Dividends
Veracyte Inc’s next quarterly earnings report is expected to be released on 2024-Nov-05.
Veracyte Inc (NASDAQ:VCYT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.82% of Veracyte Inc shares, and 105.39% of them are in the hands of institutional investors. The stock currently has a share float of 106.27%. Veracyte Inc stock is held by 347.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-03-31, it held 10.1658% of the shares, which is about 7.38 million shares worth $163.65 million.
WELLINGTON MANAGEMENT GROUP LLP, with 10.1418% or 7.37 million shares worth $163.26 million as of 2024-03-31, holds the second largest percentage of outstanding shares.
